Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study. (Q54487976)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study. |
scientific article |
Statements
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study. (English)
1 reference
1 reference
A Menter
1 reference
B Strober
1 reference
R G Langley
1 reference
M Buonanno
1 reference
R Wolk
1 reference
P Gupta
1 reference
S Krishnaswami
1 reference
H Tan
1 reference
J A Harness
1 reference
1 September 2012
1 reference
167
1 reference
3
1 reference
668-677
1 reference
Identifiers
1 reference